Divis Laboratories Ltd Share Price Performs Strongly Today
Divis Laboratories Ltd's shares saw an increase of 1.40%, reaching the current market price of 6141.00. This development underscores the stock's growing popularity.
Divis Laboratories Share Price Live
DIVISLAB
Live Divis Laboratories Share Price Chart
Divis Laboratories Stock Performance
Today's low₹6000.00
Today's high₹6087.50
₹6,056
52 week low₹4955.00
52 week high₹7071.50
₹6,056
Open
₹6,065.5
Prev. Close
₹6,011.5
Share Volume
3,67,912.00
Total Traded Value
₹22280.75 Cr
Market Cap
₹1,59,415.21 Cr
Dividend Yield
0.46
Divis Laboratories F & O
Divis Laboratories Fundamentals
| ROCE(TTM) | 19.56 |
|---|---|
| P/E Ratio (TTM) | 67.84 |
| P/B Ratio | 10.39 |
| Industry P/E | 35.35 |
| Debt to Equity | N/A |
| ROE | 15.32 |
| EPS (TTM) | 98.81 |
| Dividend Yield | 0.46 |
| Book Value | 631.38 |
| Face Value | 2 |
| ROCE(TTM) | 19.56 |
|---|---|
| P/E Ratio (TTM) | 67.84 |
| P/B Ratio | 10.39 |
| Industry P/E | 35.35 |
| Debt to Equity | N/A |
| ROE | 15.32 |
|---|---|
| EPS (TTM) | 98.81 |
| Dividend Yield | 0.46 |
| Book Value | 631.38 |
| Face Value | 2 |
Divis Laboratories Ltd Shareholding Pattern
Promoters
51.88%
Retail And Others
8.61%
Foreign Institutional Investors
20.29%
Domestic Institutional Investors
19.22%
About Divis Laboratories
History of Divis Laboratories
Divi’s Research Centre was established in 1990, and its first manufacturing facility was built in 1995 near Hyderabad. The centre had been built with research and development as its primary goal. During 1991-93, the company successfully developed several commercial processes for intermediates and bulk actives. In the year 1994, the company changed its name to Divis Laboratories Ltd to reflect their growing area of operations. In 2003, a new research centre named 'DRC-Vizag' was built by the company for research in more niche segments. In 2003, Divi’s Laboratories was listed on the Indian stock exchanges. In 2006-07, Divi’s developed an SEZ titled 'Divi's Pharma SEZ' near Visakhapatnam. In the following year, the company set up production and utility facilities in the SEZ and EOU units. They commissioned a Nutraceuticals Manufacturing facility at Divi's Pharma SEZ. In 2023, the company set up a third manufacturing plant (Unit-III) in Kakinada, Andhra Pradesh. Over the years, the company has passed multiple inspections by the USFDA as well as other major drug inspection agencies of foreign countries.Divis Laboratories Business Segments
Divi’s Laboratories manufactures generic and customised active pharmaceutical ingredients (APIs) and intermediates along with Nutraceuticals for a global audience. Their business segments can be categorised as:- Generic APIs: These include large volumes of standard medicine in tens to thousands of tonnes each year, exported to over 100 countries. Divi’s manufactures 30 APIs commercially, and 10 more APIs are in various stages of R&D/pilot project stage. Divi’s is one of the top 2 API manufacturers globally for 18 out of these 30 molecules.
- Custom Synthesis: These include APIs that have been custom-built based on the requirements of major clients. 12 out of the top 20 companies across the US, EU and Japan have been clients of Divi’s for over 10 years.
- Nutraceutical: The company's Vishakhapatnam unit produces Carotenoids. It is currently supplying carotenoids to all major food, dietary supplement and feed manufacturers globally. The company also offers customised ingredient solutions in liquids, beadlets and powder forms.
Divis Laboratories Management Team
Dr. Murali K. Divi, Founder and Managing Director Dr. Divi is the Founder and Managing Director of Divi’s Laboratories Ltd. He oversees major technical and financial operations of the company. Before starting Divi’s, Dr. Divi had more than 15 years of experience in the pharma industry and has led various global research and manufacturing teams. He holds a Ph.D. degree in Pharmaceutical Sciences from Kakatiya University and is also a member of the American Institute of Chemical Engineers and the American Chemical Society. Dr. Kiran S. Divi, CEO Dr. Kiran Divi is the Director on the Board and is the Chief Executive Officer at Divi’s Laboratories Ltd. He has been with Divi’s for the past 20 years. He took charge as the as the CEO in January 2020. He studied Pharmacy at JNTU, India and also holds a Ph.D. degree from the Gandhi Institute of Technology and Management, Visakhapatnam.Divis Laboratories Corporate Action
Bonus Shares Divi’s Laboratories had announced bonus shares last in 2015, in the ratio of 1:1. Before that, it had issued a 1:1 bonus share as well, in 2009. Stock Split Divis Laboratories had split the face value of its shares from ₹10 to ₹2 in 2007.Divis Laboratories Financial Highlights
- The company has steadily increased its total revenue from ₹816 crore in March 2013 to ₹2,370 crore in March 2023.
- The company has a large amount of assets. As of September 2023, its current ratio and quick ratio are 8.46 and 5.73, respectively.
- The company has consistently increased its investment in land, building and plant and machinery.
- It has also built up a massive inventory and trade receivables, which contributes to a large current ratio.
Parent Organisation
Indian Private
Managing Director
NA
Founded
1990
NSE Symbol
DIVISLAB
Top Mutual Funds Invested in Divis Laboratories Share
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,610.1 -28.80 (-1.76%) | ₹3,93,322.98 | 1,548.0 - 1,851.2 |
| Torrent Pharmaceuticals Ltd | 3,959.0 -38.40 (-0.96%) | ₹1,35,349.41 | 2,886.45 - 4,107.2 |
| Cipla Ltd | 1,322.2 9.20 (0.70%) | ₹1,06,048.24 | 1,281.7 - 1,673.0 |
| Dr Reddys Laboratories Ltd | 1,224.3 -15.50 (-1.25%) | ₹1,03,494.16 | 1,020.0 - 1,379.7 |
| Lupin Ltd | 2,132.7 -17.80 (-0.83%) | ₹98,102.11 | 1,795.2 - 2,226.3 |
| Zydus Lifesciences Ltd | 896.25 2.90 (0.32%) | ₹89,901.98 | 795.0 - 1,059.05 |
Popular Stocks
Divis Laboratories Latest News
Solid Surge in Divis Laboratories Ltd Stock Price Today. Divis Laboratories Ltd Up by 1.40%
Divis Laboratories Ltd's stock has surged by 1.40%, and it is currently trading at 6141.00. Additionally, the stock maintains a PE ratio of None, while the industry PE is None.
Live Market Data: Divis Laboratories Ltd Share Price Today
Following a noteworthy 1.40% increase, Divis Laboratories Ltd's shares are now trading at 6141.00. When it comes to valuation, this stock has a PE ratio of 83.3300, with the industry PE ratio at 35.9979.
Divis Laboratories Ltd FAQs
What is the share price of Divis Laboratories Ltd (DIVISLAB) shares?
Divis Laboratories Ltd (DIVISLAB) share price as of July 1, 2026, on NSE is Rs 6570 (NSE) and Rs 6570 (BSE) on BSE.
Can I buy Divis Laboratories Ltd (DIVISLAB) from Angel One?
Yes, You can buy Divis Laboratories Ltd (DIVISLAB) shares by opening a Demat account with Angel One.
How do I buy Divis Laboratories Ltd (DIVISLAB) from Angel One?
Divis Laboratories Ltd (DIVISLAB) share can be bought through the following modes:
1. Direct investment: You can buy Divis Laboratories Ltd (DIVISLAB) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Divis Laboratories Ltd (DIVISLAB) shares.
1. Direct investment: You can buy Divis Laboratories Ltd (DIVISLAB) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Divis Laboratories Ltd (DIVISLAB) shares.
What is the main business of Divis Lab?
The business produces top generic chemicals used as nutraceutical components and produces APIs and intermediates on demand for prominent international innovation firms.
Who is the owner of Divis Lab?
The owner of Divis Labs is Divi Murali. He is the Chairman and CEO of Divis Laboratories.
Who are the promoters of Divis Lab?
The promoters are Nilima Motaparti, Satchandra Kiran Divi, Nilima Prasad Divi, Swarna Latha Divi, Divi'S Biotech Private Limited, Murali Krishna Prasad Divi, Madhusudana Rao Divi, Babu Rajendra Prasad Divi, Radhakrishna Rao Divi.
What is the market cap of Divis Laboratories?
The market cap of Divis Laboratories is Rs. 166620.03 Cr. as of 01/07/2026.
What is the current P/E ratio of Divis Laboratories?
The P/E ratios of Divis Laboratories is 67.21 as of 01/07/2026.
What is the current PB ratio of Divis Laboratories?
The PB ratios of Divis Laboratories is 10.81 as of 01/07/2026.
